Fletcher Payne
Equibles does not estimate personal net worth.
Get an email with a short summary when Gyre Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get GYRE alertsAbout Fletcher Payne
Fletcher Payne is recorded as CFO at Gyre Therapeutics, Inc. (GYRE). The newest filing on record that lists Fletcher Payne as CFO at Gyre Therapeutics, Inc. (GYRE) is dated May 1, 2020. The proxy statement of Gyre Therapeutics, Inc. reports total compensation of $471,208 for Fletcher Payne in fiscal 2019, including a base salary of $252,800. Disclosed compensation is on record for 2 fiscal years. Gyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gyre Therapeutics, Inc. includes Charles Wu (CEO and Board Member), Dr. Han Ying (CEO), Dr. Ying Luo (CEO and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed May 1, 2020
Company network
Leadership on record at Gyre Therapeutics, Inc.
- Charles Wu CEO, Board Member
- Dr. Han Ying CEO
- Dr. Ying Luo CEO, Board Member
- Ping Zhang CEO, Board Member
- Ying Luo CEO, Board Member
- Ying Luo, Ph.D. CEO, Board Member
- Augustine Lawlor Chairman, Board Member
- Songjiang Ma Chairman, Board Member
- Clinton Musil CFO
- Ruoyu Chen CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Gyre Therapeutics, Inc. (GYRE) | Former Chief Financial Officer | $252,800 | $471,208 |
| 2018 | Gyre Therapeutics, Inc. (GYRE) | Former Chief Financial Officer | $345,301 | $969,476 |
Recent activity
No call appearances or filed executive changes recorded yet.